Cart
sales@molnova.com
P7C3-OMe
CAS No. 313268-18-7
P7C3-OMe( —— )
Catalog No. M22944 CAS No. 313268-18-7
P7C3-OMe, a pro-neurogenic agent, has therapeutic benefits in neurodegenerative diseases. The R-enantiomer of P7C3-OMe is far more active than the S-enantiomer.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 65 | In Stock |
|
| 5MG | 62 | In Stock |
|
| 10MG | 91 | In Stock |
|
| 25MG | 185 | In Stock |
|
| 50MG | 259 | In Stock |
|
| 100MG | 379 | In Stock |
|
| 200MG | 541 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameP7C3-OMe
-
NoteResearch use only, not for human use.
-
Brief DescriptionP7C3-OMe, a pro-neurogenic agent, has therapeutic benefits in neurodegenerative diseases. The R-enantiomer of P7C3-OMe is far more active than the S-enantiomer.
-
DescriptionP7C3-OMe, a pro-neurogenic agent, has therapeutic benefits in neurodegenerative diseases. The R-enantiomer of P7C3-OMe is far more active than the S-enantiomer.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number313268-18-7
-
Formula Weight504.21
-
Molecular FormulaC22H20Br2N2O2
-
Purity>98% (HPLC)
-
SolubilityDMSO:100 mg/mL (198.33 mM)
-
SMILESOC(CNC1=CC=CC(OC)=C1)CN2C3=C(C4=C2C=CC(Br)=C4)C=C(Br)C=C3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Pieper AA, et al. Discovery of a proneurogenic, neuroprotective chemical. Cell. 2010 Jul 9;142(1):39-51.
molnova catalog
related products
-
TH5427
TH5427 is a lead NUDT5 inhibitor(MG assay IC50?=?29?nM).
-
Angiotensin II Antip...
Angiotensin II antipeptide, a peptide, is an inverse agonist of AR1 receptor. Angiotensin II antipeptide is encoded by mRNA, complementary to that encoding Angiotensin II itself.
-
LC-MB12
LC-MB12 is an orally active, selective and potent PROTAC FGFR2 complex that degrades FGFR2.LC-MB12 has antiproliferative and antitumor activity.
